Article

Intellectual Property & Technology Law Journal | Cannabis Brand Protection in the United States: An Evolving Landscape

January 2024 – Intellectual Property & Technology Law Journal

Federal trademark law provides national trademark rights based on use in interstate commerce. This broad protection is challenging to cannabis brand owners, since a federal trademark registration in the United States Patent and Trademark Office (USPTO) may only be acquired for goods and services that are legal under federal law. The Controlled Substances Act restricts the interstate sale of controlled substances, such as cannabis products, except for products made from hemp limited to a percentage of no greater than delta-9 THC products, as consistent with the 2018 Agricultural Improvement Act (the 2018 Farm Bill). The Food and Drug Administration (FDA) also regulates the sale of cannabis products. To date, the FDA has only approved one cannabis-derived and three cannabis related prescription drugs.

Click here to read the full article written by Kristina Dahmann and Jacqueline Lesser and published in the Intellectual Property & Technology Law Journal

Firm Highlights